Read More

Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression

Cybin Inc (NYSE: CYBN), a Toronto-based biotechnology company focused on utilizing psychedelic drugs as an alternative to traditional psychiatric drugs, announced positive pre-clinical data, indicating that its drug, CYB003 showed strong signs of cognitive improvement in patients with Major Depressive Disorder

CYBN

Read More

Why Lucid Motors Shares Are Trading Higher Today

Shares of Lucid Group Inc (NASDAQ: LCID) traded higher Thursday morning, opening up nearly 5% and then reaching as high as nearly 40% higher from Wednesday’s close in anticipation of deliveries of the company's Lucid Air, which will begin October 30 with the exclusive

HTZZ